Genomics in Drug Discovery and Development
Dimitri Semizarov, Eric Blomme
Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug development professionals, and pharmaceutical scientists.
Categorie:
Anno:
2008
Edizione:
1
Casa editrice:
Wiley
Lingua:
english
Pagine:
496
ISBN 10:
0470409762
ISBN 13:
9780470409763
File:
PDF, 4.73 MB
IPFS:
,
english, 2008
Amazon 
Barnes & Noble 
Bookshop.org 
Converti i file
Più risultati di ricerca
Altri vantaggi 
